InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (2 ops.)
Browse the complete record of transactions filed by HEALY JAMES, Director. Director active across 4 companies, notably Natera, Inc.. Aggregated, 13 reports have been published. Total volume traded: €6.9m. The latest transaction was filed on 29 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
€3m27,777 shares@ €116.774996.1% of flow
Common Stock
SEC:0001104659-22-076722:0·
Ideal exit: 26 Mar 2023 (T+270)
1,307 shares
Common Stock
SEC:0001415889-22-005861:0·
€5,49247 shares@ €116.84950.2% of flow
Common Stock
SEC:0001104659-22-046068:0·
Ideal exit: 27 Dec 2022 (T+270)
5,248,949 shares
Common Stock
SEC:0001209191-22-003192·
5,248,949 shares
Common Stock
SEC:0001209191-22-003192:0·
€2m100,150 shares@ €15.4401100.0% of flow
Common Stock, $0.0001 par value
SEC:0001104659-21-120896·
€2m100,150 shares@ €15.44010.90% mcap50.0% of flow
Common Stock, $0.0001 par value
SEC:0001104659-21-120896:0·
€230,3632,400 shares@ €95.98450.0009% mcap100.0% of flow
Common Stock
SEC:0001104659-21-095961·
Ideal exit: 18 Apr 2022 (T+270)
€230,3632,400 shares@ €95.98450.0009% mcap50.0% of flow
Common Stock
SEC:0001104659-21-095961:0·
Ideal exit: 18 Apr 2022 (T+270)
€63,246636 shares@ €99.4439100.0% of flow
Common Stock
SEC:0001104659-21-089894·
Ideal exit: 29 Mar 2022 (T+270)
€63,246636 shares@ €99.44391.9% of flow
Common Stock
SEC:0001104659-21-089894:0·
Ideal exit: 29 Mar 2022 (T+270)
2,856 shares
Common Stock
SEC:0001415889-21-002772·
2,856 shares
Common Stock
SEC:0001415889-21-002772:0·
13 of 13 declarations
About HEALY JAMES
James Healy is a Board Member at Natera, Inc., Karuna Therapeutics, Inc., and Coherus BioSciences, Inc. He brings expertise in biotechnology and corporate strategy, playing a key role in the governance and direction of the companies. His commitment is essential for the development of innovative solutions in the healthcare sector.
